Cellular, Tissue and Gene Therapies Advisory Committee
(Formerly Biological Response Modifiers Advisory Committee)
May 9-10, 2002 Meeting
Date and Time:
The meeting will be held on May 9, 2002, 8:00 a.m. to 6:30 p.m.; and May 10, 2002, 8:00 a.m. to 3:00 p.m.
Location:
Hilton Hotel, 620 Perry Parkway, Gaithersburg, MD 20877, 301-977-8900
Contact Person:
Gail Dapolito or Rosanna L. Harvey, 301-827-0314, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 12389. Please call the Information Line for up-to-date information on this meeting.
Agenda:
On May 9, 2002, at 8:00 a.m. the committee receives updates of research programs in the Division of Therapeutic Proteins and the Division of Monoclonal Antibodies, at 9:00 a.m. the committee discusses issues related to ooplasm transfer in assisted reproduction. On May 10, 2002, the committee discusses issues related to inadvertent germline transmission of gene transfer vectors.
Oral Presentations:
Between approximately 3:35 p.m. and 4:05 p.m. on May 9, and from 11:40 a.m. to 12:10 p.m. on May 10, oral presentations from the public will be scheduled. Those desiring to make formal oral presentations should notify the contact person before May 2, 2002.
Closed Committee Deliberations:
On May 9, 2002, from 8:45 a.m. to 9:00 a.m. the meeting will be closed to permit discussion where disclosure would constitute a clearly unwarranted invasion of personal privacy (5 U.S.C. 552b(c)(6)).
|
